Title:
NOVEL PHARMACEUTICAL FORMULATIONS
Document Type and Number:
WIPO Patent Application WO/2015/120110
Kind Code:
A3
Abstract:
The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. In certain embodiments, disclosed herein is an extended-release pharmaceutical formulation comprising, in a solid dosage form for oral delivery of between about 100 mg and about 1 g total weight: between about 2 and about 18% of an active ingredient; between about 70% and about 96% of one or more diluents; between about 1% and about 10% of a water-soluble binder and between about 0.5 and about 2% of a surfactant.
More Like This:
Inventors:
SOMMER ANDREAS (US)
ZHANG CHENGZHI (US)
CARTER JOHN (US)
ARTHUR JOHN (US)
BRADBURY MARGARET (US)
ZHANG CHENGZHI (US)
CARTER JOHN (US)
ARTHUR JOHN (US)
BRADBURY MARGARET (US)
Application Number:
PCT/US2015/014545
Publication Date:
November 19, 2015
Filing Date:
February 05, 2015
Export Citation:
Assignee:
AUSPEX PHARMACEUTICALS INC (US)
International Classes:
C07D455/06
Foreign References:
US20110053866A1 | 2011-03-03 | |||
US20080299204A1 | 2008-12-04 | |||
US20100130480A1 | 2010-05-27 | |||
US20100055133A1 | 2010-03-04 | |||
US20150004231A1 | 2015-01-01 |
Other References:
See also references of EP 3102190A4
Attorney, Agent or Firm:
BENNETT, Dennis, A. (LLC1005 N.. Warson Road, Suite 40, St. Louis MO, US)
Download PDF:
Previous Patent: METHODS OF FORMING LAMINATED GLASS STRUCTURES
Next Patent: EXPEDIENT SYNTHESIS OF SITAGLIPTIN
Next Patent: EXPEDIENT SYNTHESIS OF SITAGLIPTIN